Evidence base and strategies for successful smoking cessation
- PMID: 20223623
- DOI: 10.1016/j.jvs.2009.10.124
Evidence base and strategies for successful smoking cessation
Abstract
The burden of tobacco dependence can be measured in premature deaths due to accelerated atherosclerotic disease and cancer, and economic costs of lost productivity and intensified medical care. Smoking cessation efforts have benefited from continued pharmacologic developments, increased public awareness of stop-smoking programs, aggressive counter-campaigns to illustrate the toll of cigarette smoking, and recognition of the many primary and secondary effects of smoking exposure on the general public. Vascular surgeons and interventionalists, as well as vascular medicine specialists, are uniquely positioned to engage and educate the patient to promote cessation, monitor for continued abstinence, and assist in efforts to avoid relapses. This article reviews the effects of tobacco dependence on peripheral arterial disease, perioperative considerations in smokers, as well as common clinical interventions such as counseling and pharmacotherapy to encourage tobacco cessation.
Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Smoking cessation intervention: an evidence-based approach.Postgrad Med. 2010 Mar;122(2):74-82. doi: 10.3810/pgm.2010.03.2124. Postgrad Med. 2010. PMID: 20203458 Review.
-
Smoking cessation counseling in vascular surgical practice using the results of interviews and focus groups in the Vascular Surgeon offer and report smoking cessation pilot trial.J Vasc Surg. 2016 Apr;63(4):1011-7.e2. doi: 10.1016/j.jvs.2015.10.086. Epub 2015 Dec 30. J Vasc Surg. 2016. PMID: 26747682 Free PMC article. Clinical Trial.
-
The number of smokers needed to screen and treat in a smoking cessation programme.Eur J Cardiovasc Prev Rehabil. 2009 Dec;16(6):669-76. doi: 10.1097/HJR.0b013e32832f4465. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19738472
-
Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.J Vasc Surg. 2008 May;47(5):1108-15. doi: 10.1016/j.jvs.2007.12.033. Epub 2008 Apr 18. J Vasc Surg. 2008. PMID: 18372155
-
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.Cardiol Rev. 2007 May-Jun;15(3):154-61. doi: 10.1097/01.crd.0000260270.12829.45. Cardiol Rev. 2007. PMID: 17438382 Review.
Cited by
-
Design and initial enrollment in the Vascular Physicians Offer and Report (VAPOR) trial.J Vasc Surg. 2016 Apr;63(4):1121-5.e2. doi: 10.1016/j.jvs.2015.12.026. J Vasc Surg. 2016. PMID: 27016862 Free PMC article. Clinical Trial.
-
Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.Clin Res Cardiol. 2013 Feb;102(2):95-101. doi: 10.1007/s00392-012-0499-0. Epub 2012 Aug 10. Clin Res Cardiol. 2013. PMID: 22878732
-
Assessment of smoking behaviour in the dental setting. A study comparing self-reported questionnaire data and exhaled carbon monoxide levels.Clin Oral Investig. 2012 Jun;16(3):755-60. doi: 10.1007/s00784-011-0583-2. Epub 2011 Jun 30. Clin Oral Investig. 2012. PMID: 21717094
-
Smoking and olfactory dysfunction: A systematic literature review and meta-analysis.Laryngoscope. 2017 Aug;127(8):1753-1761. doi: 10.1002/lary.26558. Epub 2017 May 31. Laryngoscope. 2017. PMID: 28561327 Free PMC article.
-
Tobacco and the escalating global cancer burden.J Oncol. 2011;2011:408104. doi: 10.1155/2011/408104. Epub 2011 Aug 18. J Oncol. 2011. PMID: 21869888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical